<DOC>
	<DOCNO>NCT01833585</DOCNO>
	<brief_summary>The purpose study determine safety efficacy G-CSF-mobilized autologous peripheral blood mononuclear cell injection ischemic limbs patient critical limb ischemia .</brief_summary>
	<brief_title>Treatment Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Gangrene</mesh_term>
	<criteria>Patients critical limb ischemia confirm toe pressure , ABI , TCOM Levels arterial occlusion femoropopliteal tibioperoneal occlusion Poor distal artery runoff Age 1870 year Planned major amputation within 4 week Receive blood component within 4 week Acute myocardial infarction severe valvular heart disease renal failure liver failure Cancer Hypercoagulable state Severe infection Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>ischemic ulcer</keyword>
	<keyword>rest pain</keyword>
	<keyword>gangrene</keyword>
</DOC>